Orthopädische Universitätsklinik Basel, Basel, Switzerland.
Am J Sports Med. 2009 Nov;37(11):2117-25. doi: 10.1177/0363546509348047.
Despite advances in the treatment of ruptured Achilles tendon, imperfections of endogenous repair often leave patients symptomatic. Local administration of autologous conditioned serum (ACS) in patients with inflammatory, degenerative conditions has shown beneficial effects.
Because ACS also contains growth factors that should accelerate tendon healing, we studied the effect of ACS on the healing of transected rat Achilles tendon.
Controlled laboratory study.
In preliminary in vitro experiments, rat tendons were incubated with ACS and the effect on the expression of Col1A1 and Col3A1 was assessed by real-time quantitative polymerase chain reaction. To test its effect in vivo, the Achilles tendons of 80 Sprague Dawley rats were transected and sutured back together. Ten rats from each group (ACS group, n = 40; control group, n = 40) were euthanized at 1, 2, 4, and 8 weeks postoperatively for biomechanical (n = 7) and histologic (n = 3) testing. Lysyl oxidase activity was assayed by a flurometric assay. The organization of repair tissue was assessed histologically with hematoxylin and eosin- and with Sirius red-stained sections, and with immunohistochemistry.
Tendons exposed to ACS in vitro showed a greatly enhanced expression of the Col1A1 gene. The ACS-treated tendons were thicker, had more type I collagen, and an accelerated recovery of tendon stiffness and histologic maturity of the repair tissue. However, there were no differences in the maximum load to failure between groups up to week 8, perhaps because lysyl oxidase activities were unchanged.
Overall, our study demonstrates that treatment with ACS has the potential to improve Achilles tendon healing and should be considered as a treatment modality in man. However, as strength was not shown to be increased within the parameters of this study, the clinical importance of the observed changes in humans still needs to be defined.
尽管在治疗跟腱断裂方面取得了进展,但内源性修复的不完美常常使患者仍有症状。在患有炎症性、退行性疾病的患者中,局部应用自体条件血清(ACS)已显示出有益的效果。
由于 ACS 还含有应加速肌腱愈合的生长因子,我们研究了 ACS 对切断的大鼠跟腱愈合的影响。
对照实验室研究。
在初步的体外实验中,将大鼠肌腱与 ACS 孵育,并通过实时定量聚合酶链反应评估 Col1A1 和 Col3A1 的表达变化。为了测试其在体内的效果,将 80 只 Sprague Dawley 大鼠的跟腱切断并重新缝合在一起。每组(ACS 组,n = 40;对照组,n = 40)各有 10 只大鼠在术后 1、2、4 和 8 周时安乐死,用于生物力学(n = 7)和组织学(n = 3)测试。通过荧光测定法测定赖氨酰氧化酶活性。通过苏木精和伊红染色以及天狼星红染色切片和免疫组织化学评估修复组织的结构。
体外暴露于 ACS 的肌腱显示出 Col1A1 基因的表达大大增强。用 ACS 处理的肌腱更厚,有更多的 I 型胶原,并且肌腱刚度和组织学成熟度的恢复更快。然而,直到第 8 周,两组之间的最大失效负载没有差异,这可能是因为赖氨酰氧化酶活性没有改变。
总的来说,我们的研究表明,用 ACS 治疗具有改善跟腱愈合的潜力,应被视为一种治疗方法。然而,由于在这项研究的参数范围内没有显示出强度增加,因此仍需要确定在人类中观察到的变化的临床重要性。